@article{1d6e9763bc5741e5869efe7812d04760,
title = "Facebook use and body dissatisfaction moderate the association between discrimination and suicidality among LGBQ individuals",
abstract = "Lesbian, gay, bisexual, and queer (LGBQ) individuals experience increased discrimination and suicidality compared to their heterosexual counterparts. Given this disparity, an increasing number of studies have been exploring the effect of social media use on LGBQ people's well-being and mental health, yet results are largely inconsistent, even contradictory. Using data collected from 1799 Israeli LGBQ individuals, this study examined the association between sexual orientation-based discrimination and suicidality, before testing the moderating effects of LGBTQ Facebook use (defined as engagement with LGBTQ people and content on Facebook) and body dissatisfaction on the discrimination-suicidality association. We established a positive association between discrimination and suicidality and showed that the effect of Facebook engagement with LGBTQ peers and content on this association depends on users' level of dissatisfaction with their bodies. These findings illuminate the role of social media in LGBQ people's well-being and reaffirm the importance of body image within the LGBQ community.",
keywords = "Body dissatisfaction, Body image, Discrimination, Facebook, LGBQ, LGBTQ, Social media, Suicidality",
author = "Avi Marciano and Yossi David and Nadav Antebi-Gruszka",
note = "Funding Information: C. Specker has received honoraria for consulting from AbbVie, Boehringer Ingelheim, Chugai, Lilly, Novartis, Sobi and UCB; speakers{\textquoteright} bureau from AbbVie, Celgene, Chugai, Janssen- Cilag, Lilly, MSD, Novartis, Pfizer, Roche and UCB; and grant/research/ study support from Boehringer, Chugai, GSK and Roche. A. Alberding has received support for this study from Roche and Chugai that went directly to her employer. M. Aringer has received consulting fees (or other payment) from Roche and Chugai; speakers{\textquoteright} bureau from Roche and Chugai; and grant/research/study support from Roche. G.-R. Burmester has received consult ing fees from Lilly, Pfizer, Sanofi and Roche; and grant/research/study support from Roche. J.-P. Flacke is an employee of Roche Pharma AG. M.W. Hofmann is an employee of Chu-gai Pharma Germany GmbH. P. K{\"a}stner has received grant/research/ study support from Roche. H. Kellner has received consulting fees from Roche and has received grant/research/study support from Roche. F. Moosig has received grant/research/ study support from Roche. M. Sieburg has received grant/research/ study support from Roche. H.-P. Tony has received consulting fees from Roche, Abbvie, BMS, Chugai, Janssen, Novartis, Sanofi and Lilly; has received speakers{\textquoteleft} bureau from Roche, Abbvie, BMS, Chugai, Jans-sen, Novartis, Sanofi and Lilly; and has received grant/research/study support from Roche. G. Fliedner has received grant/research/ study support from Roche. Funding Information: We thank the patients, their families and all of the centres that participated in ICHIBAN. Writing support was provided by Physicians World Europe GmbH (Mannheim, Germany), supported by Roche Pharma AG. Funding Information: Trial registration no.: ClinicalTrials.gov, number NCT01194401; ML22928 Funding: this study was supported by Roche Pharma AG (Grenzach-Wyhlen, Germany) and Chugai Pharma Germany GmbH (Frankfurt am Main, Germany). For competing interests, see page 327. Publisher Copyright: {\textcopyright} 2023",
year = "2023",
month = jul,
day = "1",
doi = "10.1016/j.chb.2023.107729",
language = "American English",
volume = "144",
journal = "Computers in Human Behavior",
issn = "0747-5632",
publisher = "Elsevier Ltd.",
}